Press Release

Collaboration will apply Aignostics AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9,...

MT Group: 23-year-old biospecimen CRO marks milestone with expanded capabilities for translational research, biomarker discovery, companion diagnostic development, and liquid biopsy validation across oncology and autoimmune programs LOS...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, Yale New Haven Hospital (YNHH) and Memorial Sloan Kettering Cancer Center (MSK) today announced the...

Proscia: National group positions itself as key partner for biopharmaceutical research, strengthening its role in precision medicine MELBOURNE, FL and PHILADELPHIA — June 3, 2026 — NextGen Pathology, a national group of general and...

Mach7: Company to highlight enterprise imaging workflows, enterprise viewing, and digital pathology capabilities at Booth 608 BURLINGTON, Vt., June 1, 2026 /PRNewswire/ -- Mach7 Technologies (ASX:M7T), a provider of...

DiaDeep and Leica Biosystems: Expanding access to integrated AI tools helps pathologists tackle complex workflows and improve insights Lyon, France and VISTA, CA — May 27, 2026  DiaDeep, a Lyon-based company specialized in medical AI for...